Yıl: 2022 Cilt: 28 Sayı: 6 Sayfa Aralığı: 736 - 742 Metin Dili: İngilizce DOI: 10.14744/tjtes.2021.01954 İndeks Tarihi: 07-11-2022

Neuroprotective effects of adrenomedullin in experimental traumatic brain injury model in rats

Öz:
BACKGROUND: Traumatic brain injuries cause damages in the brain in several ways, which include cell death because of edema, disruption of the blood–brain barrier, shear stress, and ischemia. In this study, we investigated the effects of adrenomedullin (AM) on oxidative stress and inflammation after head traumas in a rat model. METHODS: Eighteen male adult Wistar albino rats were randomized into three groups (n=6). No traumas were applied to the con- trol (C) group. Traumas were applied in line with Marmarau trauma model in the trauma group. The rats in the AM treatment group were treated with post-traumatic 12 μg/kg i.p. AM in addition to the trauma group. The rats were followed for 7 days in all groups and were then sacrificed. Brain tissues and blood samples were taken. RESULTS: In the trauma group, both tissue and serum MDA, TNF-α, and IL-6 levels were significantly increased compared to the control group (p<0.05). In the AM-treated group, serum TNF-α levels were significantly decreased compared to the trauma group (p<0.05). In the trauma group, both tissue and serum GSH levels were significantly decreased compared to the control group (p<0.05). In the trauma group, serum Vitamin D3 levels were significantly decreased compared to the control group (p<0.05). In the AM-treated group, both tissue and serum GSH levels were significantly increased compared to the trauma group (p<0.05). CONCLUSION: These results indicate that AM has neuroprotective effects on traumatic brain injury in a rat model.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Diğer Erişim Türü: Erişime Açık
  • 1. Werner CK. Pathophysiology of traumatic brain injury. Br J Anaesth 2007;99:4–9.
  • 2. Schmidt OI, Heyde CE, Ertel W, Stahel PE. Closed head injury-an in- flammatory disease? Brain Res Rev 2005;483:388–99.
  • 3. Shohami E, Novikov M, Bass R. Closed head injury triggers early pro- duction of TNF-α and IL-6 by brain tissue. J Cereb Blood Flow Metab 1994;14:615–9.
  • 4. Kossmann T, Hans V, Imhof HG. Intrahecal and serum interleukin-6 and acute phase response in patients with severe traumatic brain injuries. Shock 1995;5:311–7.
  • 5. De Feudis FV. Ginkgo biloba extract (EGb 761) pharmacological activity and clinical applicatons. In: Effects of Egb 761 on the CNS. Tokyo: El- seiver; 1991. p. 551–6.
  • 6. Hall ED, Braughler JM. Central nervous system travma and stroke. II. Physiological and pharmacological evidence for involment of oxygen free radicals and lipid peroxidation. Free Radic Biol Med 1989;6:303–13.
  • 7. Menku E, Ogden M, Saraymen R. The protective effects of propofol and citicoline combination in experimental head injury in rats. Turk Neuro- surg 2010;20:57–62.
  • 8. Dumont RJ, Okonkwo DO, Verma S, Hurlbert J. Acute spinal cord injury, part I: Pathophysiologic mechanisms. Clin Neuropharmacol 2001;24:254–64.
  • 9. Topsakal C, Kilic N, Ozveren F, Akdemir I, Kaplan M, Tiflikci M. Ef- fects of prostaglandin E1, melatonin, and oxytetracycline on lipid per- oxidation, antioxidant defense system, paraoxonase (PON1) activities, and homocysteine levels in an animal model of spinal cord injury. Spine 2003;28:1643–52.
  • 10. Yanagawa B, Nagaya N. Adrenomedullin: Molecular mechanisms and its role in cardiac disease. Amino Acids 2007;32:157–64.
  • 11. Serrano J, Alonso D, Fernandez AP, Encinas JM, Lopez JC, Castro- Blanco S, et al. Adrenomedullin in the central nervous system. Mi- croscopy Res Tech 2002;57:76–90.
  • 12. Hirata Y, Mitaka C, Sato K, Nagura T, Tsunoda Y, Amaha K, et al. In- creased circulating adrenomedullin, a novel vasodilatory peptide, in sep- sis. J Clin Endocrinol Metab 1996;81:1449–53.
  • 13. Ishihara T, Kato J, Kitamura K, Katoh F, Fujimoto S, Kangawa K, et al. Production of adrenomedullin in human vascular endothelial cells. Life Sci 1997;60:1763–9.
  • 14. Cui X, Wu R, Zhou M, Dong W, Ulloa L, Yang H, et al. Adrenomedullin and its binding protein attenuate the proinflammatory response after hemorrhage. Crit Care Med 2005;33:391–8.
  • 15. Gergin İŞ. Sıçanlarda Farklı Kafa Travması Modellerinin Hipotalamo- hipofizi Eraksta Hasar Oluşturma Etkinliğinin Histolojik, Biyokimyasal Verilerle ve Davranış Testleriyle Değerlendirilmesi. Kayseri: Tıpta Uz- manlık Tezi; 2015.
  • 16. Dwivedi AJ, Wu R, Nguyen E, Higuchi S, Wang H, Krishnasastry K, et al. Adrenomedullin and adrenomedullin binding protein-1 pre- vent acute lung injury after gut ischemia-reperfusion. J Am Coll Surg 2007;205:284–93.
  • 17. Okhawa H, Ohishi N, Yagi K. Assay for lipidperoxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–8.
  • 18. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70–7.
  • 19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with the folin phenol reagent. J Biol Chem 1951;193:265–75.
  • 20. Konat GW, Wiggins RC. Effect of reactive oxygen species on myelin membrane proteins. J Neurochem 1985;45:1113–8.
  • 21. Yoshimoto T, Fukai N, Sato R, Sugiyama T, Ozawa N, Shichiri M, et al. Antioxidant effect of adrenomedullin on angiotensin II-induced reactive oxygen species generation in vascular smooth muscle cells. Endocrinology 2004;145:3331–7.
  • 22. Shimosawa T, Shibagaki Y, Ishibashi K, Kitamura K, Kangawa K, Kato S, et al. Adrenomedullin, an endogenous peptide, counteracts cardiovas- cular damage. Circulation 2002;105:106–11.
  • 23. Kato K,Yin H, Agata J,Yoshida H, Chao L, Chao J. Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2003;285:H1506–14.
  • 24. Chao J, Kato K, Zhang JJ, Dobrzynski E, Wang C, Agata J, et al. Human adrenomedullin gene delivery protects against cardiovascular remodeling and renal injury. Peptides 2001;22:1731–37.
  • 25. Kang HK, Kim DK, Lee BH, Om AS, Hong JH, Koh HC, et al. Urinary N-acetyl-beta-D-glucosaminidase and malondialdhyde as a markers of renal damage in burned patients. J Korean Med Sci 2001;16:598–602.
  • 26. Meister A. Glutathione deficiency produced by inhibition of its synthesis and its reversal applications in research and therapy. Pharmacol Thera- peut 1991;51:155–94.
  • 27. Suner IH, Kurt G, Yildirim Z, Bulduk EB, Borcek AO, Demirci H, et al. Investigation of the effect of alemtuzumab in an experimental spinal cord trauma model in rats. World Neurosurg 2019;121:E723–30.
  • 28. Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of cal- cium or calcium in combination with vitamin D supplementation to pre- vent fractures and bone loss in people aged 50 years and older: A meta- analysis. Lancet 2007;370:657–66.
  • 29. Jamall OA, Feeney C, Zaw-Linn J, Malik A, Niemi ME, Tenorio-Jimenez C, et al. Prevalence and correlates of vitamin D deficiency in adults after traumatic brain injury. Clin Endocrinol 2016;85:636–44.
  • 30. Cekic M, Cutler SM, Vanlandingham JW, Stein DG. Vitamin D defi- ciency reduces the benefits of progesterone treatment after brain injury in aged rats. Neurobiol Aging 2011;32:864–74.
  • 31. Gong G, Yuan LB, Hu L, Wu W, Yin L, Hou JL, et al. Glycyrrhizin at- tenuates rat ischemic spinal cord injury by suppressing inflammatory cy- tokines and HMGB1. Acta Pharmacol Sin 2012;33:11–8.
  • 32. Hasturk A, Atalay B, Caliskaneller T, Ozdemir O, Oruckaptan H, Alti- nors N. Analysis of serum pro-inflammatory cytokine levels after rat spinal cord ischemia/reperfusion injury and correlation with tissue dam- age. Turk Neurosurg 2009;19:353–9.
  • 33. Smith PD, Puskas F, Meng X, Lee JH, Cleveland JC Jr., Weyant MJ, et al. The evaluation of chemokine release supports a bimodal mechanism of spinal cord ischemia and reperfusion injury. Circulation 2012;126: S110–7.
  • 34. Celik H, Karatay M, Erdem Y, Yildirim AE, Sertbas I, Karatay E, et al. The biochemical, histopathological and clinical comparison of the neuro- protective effects of subcutaneous adalimumab and intravenous methl- prednisolone in an experimental compressive spinal cord trauma model. Turk Neurosurg 2016;26:622–31.
  • 35. Demir H, Onur OE, Denizbasi A, Akoglu H, Eroglu SE, Ozpolat C, et al. The effects of adrenomedullin in traumatic brain injury. Peptides 2013;43:27–31.
  • 36. Zhou YQ, Liu DQ, Chen SP, Sun J, Wang XM, Tian YK, et al. Minocy- cline as a promising therapeutic strategy for chronic pain. Pharmacol Res 2018;134:305–10.
  • 37. Karatepe O, Kurtulus I, Yalcın O, Battal M, Kamali G, Aydin T. Adrenomedulline improves ischemic left colonic anastomotic healing in an experimental rodent model. Clinics 2011;66:1805–10.
  • 38. Feng JL, Zheng SR, Wang DM. Adrenomedullin: An important partici- pant in neurological diseases. Neural Regen Res 2020;15:1199–207. 333333333 39. Martinez-Herrero S, Larrayoz IM, Ochoa-Callejero L, Garcia-San- martin J, Martinez A. Adrenomedullin as a growth and cell fate regula- tory factor for adult neural stem cells. Stem Cells Int 2012;2012:1–18.
APA Emmez G, BULDUK E, Yıldırım Z (2022). Neuroprotective effects of adrenomedullin in experimental traumatic brain injury model in rats. , 736 - 742. 10.14744/tjtes.2021.01954
Chicago Emmez Gökçen,BULDUK ERKUT BAHA,Yıldırım Zuhal Neuroprotective effects of adrenomedullin in experimental traumatic brain injury model in rats. (2022): 736 - 742. 10.14744/tjtes.2021.01954
MLA Emmez Gökçen,BULDUK ERKUT BAHA,Yıldırım Zuhal Neuroprotective effects of adrenomedullin in experimental traumatic brain injury model in rats. , 2022, ss.736 - 742. 10.14744/tjtes.2021.01954
AMA Emmez G,BULDUK E,Yıldırım Z Neuroprotective effects of adrenomedullin in experimental traumatic brain injury model in rats. . 2022; 736 - 742. 10.14744/tjtes.2021.01954
Vancouver Emmez G,BULDUK E,Yıldırım Z Neuroprotective effects of adrenomedullin in experimental traumatic brain injury model in rats. . 2022; 736 - 742. 10.14744/tjtes.2021.01954
IEEE Emmez G,BULDUK E,Yıldırım Z "Neuroprotective effects of adrenomedullin in experimental traumatic brain injury model in rats." , ss.736 - 742, 2022. 10.14744/tjtes.2021.01954
ISNAD Emmez, Gökçen vd. "Neuroprotective effects of adrenomedullin in experimental traumatic brain injury model in rats". (2022), 736-742. https://doi.org/10.14744/tjtes.2021.01954
APA Emmez G, BULDUK E, Yıldırım Z (2022). Neuroprotective effects of adrenomedullin in experimental traumatic brain injury model in rats. Ulusal Travma ve Acil Cerrahi Dergisi, 28(6), 736 - 742. 10.14744/tjtes.2021.01954
Chicago Emmez Gökçen,BULDUK ERKUT BAHA,Yıldırım Zuhal Neuroprotective effects of adrenomedullin in experimental traumatic brain injury model in rats. Ulusal Travma ve Acil Cerrahi Dergisi 28, no.6 (2022): 736 - 742. 10.14744/tjtes.2021.01954
MLA Emmez Gökçen,BULDUK ERKUT BAHA,Yıldırım Zuhal Neuroprotective effects of adrenomedullin in experimental traumatic brain injury model in rats. Ulusal Travma ve Acil Cerrahi Dergisi, vol.28, no.6, 2022, ss.736 - 742. 10.14744/tjtes.2021.01954
AMA Emmez G,BULDUK E,Yıldırım Z Neuroprotective effects of adrenomedullin in experimental traumatic brain injury model in rats. Ulusal Travma ve Acil Cerrahi Dergisi. 2022; 28(6): 736 - 742. 10.14744/tjtes.2021.01954
Vancouver Emmez G,BULDUK E,Yıldırım Z Neuroprotective effects of adrenomedullin in experimental traumatic brain injury model in rats. Ulusal Travma ve Acil Cerrahi Dergisi. 2022; 28(6): 736 - 742. 10.14744/tjtes.2021.01954
IEEE Emmez G,BULDUK E,Yıldırım Z "Neuroprotective effects of adrenomedullin in experimental traumatic brain injury model in rats." Ulusal Travma ve Acil Cerrahi Dergisi, 28, ss.736 - 742, 2022. 10.14744/tjtes.2021.01954
ISNAD Emmez, Gökçen vd. "Neuroprotective effects of adrenomedullin in experimental traumatic brain injury model in rats". Ulusal Travma ve Acil Cerrahi Dergisi 28/6 (2022), 736-742. https://doi.org/10.14744/tjtes.2021.01954